A Russian researcher says he plans to edit the genomes of embryos from deaf couples, New Scientist reports.
MIT's Technology Review reports that the third 'CRISPR baby' should be due soon.
Massive Science writes that tool like CRISPR could help treat diseases like Alzheimer's, but more likely will help researchers understand such conditions better first.
The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.
The company is aiming to create a suite of products that can help researchers and manufacturers engineer various genomes at scale for multiple purposes.
The process challenges claims made in certain UC Berkeley patents on the use of CRISPR-Cas9 to edit eukaryotic genomes.
Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.
In Nature this week: CRISPR-Cas9 genome editing system that does not require double-strand DNA breaks, and more.
During the five-year collaboration, the partners will research disease-causing gene mutations and develop new CRISPR-based technologies for drug discovery.
A Russian researcher wants to implant gene-edited embryos into women this year, Nature News reports.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.